Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to PKC activation

Am J Physiol. 1997 Oct;273(4):C1233-40. doi: 10.1152/ajpcell.1997.273.4.C1233.

Abstract

Changes in endothelial cell (EC) phenotype are central to the function of endothelium in inflammation. Although these events mainly occur in the microvasculature, previous studies have predominantly used large-vessel EC. Using enzyme-linked immunosorbent and flow cytometric assays, we compared the responses of human umbilical vein endothelial cells (HUVEC) and dermal microvascular endothelial cells (DMEC) to the activation of protein kinase C (PKC). Stimulation with phorbol 12,13-dibutyrate and more selective PKC agonists, including 12-deoxyphorbol 13-phenylacetate 20-acetate (dPPA), induced morphological changes and proliferation in both EC types. PKC activation induced a marked increase in Thy-1 expression on DMEC and only a moderate rise on HUVEC. Furthermore, heterogeneity in the induction of the adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1 IVCAM-1), and E-selectin between the two EC types following activation of PKC was demonstrated. In particular, E-selectin and VCAM-1 were significantly upregulated on HUVEC but not DMEC. The data indicate that the PKC pathway is unlikely to be important for E-selectin and VCAM-1 expression in the microvasculature but are consistent with a role for PKC in angiogenesis. This diversity in signaling in response to PKC activation may depend on differential utilization of PKC isozymes and may facilitate specialized endothelial responses.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Adhesion Molecules
  • Cell Division / drug effects
  • Cells, Cultured
  • Cycloheximide / pharmacology
  • E-Selectin / biosynthesis
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology*
  • Enzyme Activation
  • Humans
  • Kinetics
  • Microcirculation
  • Phorbol 12,13-Dibutyrate / pharmacology
  • Phorbol Esters / pharmacology
  • Protein Kinase C / metabolism*
  • RNA, Messenger / biosynthesis
  • Skin / blood supply
  • Thy-1 Antigens / biosynthesis
  • Transcription, Genetic / drug effects
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Umbilical Veins
  • Vascular Cell Adhesion Molecule-1 / biosynthesis

Substances

  • Cell Adhesion Molecules
  • E-Selectin
  • Phorbol Esters
  • RNA, Messenger
  • Thy-1 Antigens
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • Phorbol 12,13-Dibutyrate
  • 12-deoxyphorbolphenylacetate
  • Cycloheximide
  • Protein Kinase C